Youtube
WINDLAS

Windlas Biotech Ltd.

₹228.5

Score

23

Technically Bearish

Windlas Biotech Price Change Analysis

Windlas Biotech Key Statistics
  • P/E Ratio

    12.9

  • PEG Ratio

    0.1

  • Market Cap Cr

    498

  • Price to Book Ratio

    181.3

  • EPS

    17.7

  • Dividend

    70 ()

  • Relative Strength Index

    43.58

  • Money Flow Index

    41.75

  • MACD Signal

    -4.29

  • Average True Range

    10.41

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Windlas Biotech Synopsis

NSE-Medical-Ethical Drugs

Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 465.93 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2022. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
  • Market Cap

    497.99

  • Sales

    465.93

  • Shares in Float

    0.87

  • No of Funds

    13

  • Yield

    1.53

  • Book Value

    1.26

  • U/D Vol Ratio

    0.7

  • LTDebt/Equity

  • Alpha

    -0.28

  • Beta

    0.82

Windlas Biotech Ownership
Windlas Biotech Management

Windlas Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Windlas Biotech Financials

Windlas Biotech Technicals

EMA & SMA

CURRENT PRICE

EMA

Windlas Biotech Resistance and Support

Windlas Biotech Delivery and Volume

Windlas Biotech Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Windlas Biotech share price is

Open Demat Account